Clinical Trial Update: Standard Induction With Basiliximab Versus No-Induction in Low Immunological Risk Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing standard induction with basiliximab versus no induction in low immunological risk kidney transplant recipients; status currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Basiliximab (basiliximab)

Snippet

Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: Kidney Transplantation | Phase 4 | Status: UNKNOWN